机构:[1]Department of Medical Laboratory Center, General Hospital of Central Theatre Command of People's Liberation Arm, Wuhan, Hubei, China.[2]Oncology Department, Maoming Hospital of Traditional Chinese Medicine, Maoming, Guangdong, China.[3]Applied Mathematics, School of Mathematics and Physics, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
Postdoctoral Science Foundation of China,
Grant/Award Number: 2022M713858
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|3 区医学
小类|3 区生化与分子生物学3 区毒理学
最新[2025]版:
大类|3 区医学
小类|3 区生化与分子生物学3 区毒理学
第一作者:
第一作者机构:[1]Department of Medical Laboratory Center, General Hospital of Central Theatre Command of People's Liberation Arm, Wuhan, Hubei, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yuan Zilin,Xiong Ba,Liu Lie,et al.Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1[J].Journal Of Biochemical And Molecular Toxicology.2024,38(2):e23656.doi:10.1002/jbt.23656.
APA:
Yuan Zilin,Xiong Ba,Liu Lie,Lu Yifan,Liu Yueping...&Tu Mingzhong.(2024).Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1.Journal Of Biochemical And Molecular Toxicology,38,(2)
MLA:
Yuan Zilin,et al."Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1".Journal Of Biochemical And Molecular Toxicology 38..2(2024):e23656